News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
07.01.2020 14:30:00

Better Buy: Illumina vs. Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) and Illumina (NASDAQ: ILMN) are two companies investors interested in genetics will want to keep a close eye on. Both stocks have done very well over the years, currently trading near their all-time highs. Although they've done well in the past, determining which one is the better buy here on out is a more difficult question to answer -- one that requires assessing where the companies are today, their relative valuations, and overall risk level.With a broad mix of revenue from multiple segments and consistent profits, Thermo Fisher Scientific offers investors stability and predictability. The company has taken on several acquisitions over the years to help with the growth of its top line, including the purchase of genetic testing company Life Technologies for $13.6 billion in 2014. From $16.9 billion in revenue in 2014, the company reported $24.4 billion in sales in 2018, an increase of more than 44% in four years.Amid all those changes, Thermo Fisher Scientific has continued to produce a strong bottom line, with its net income rising steadily during that time from $1.9 billion to nearly $3 billion in 2018. A big part of what makes the company such a stable buy is its different segments. Laboratory products and services make up more than 40% of the company's sales while life sciences solutions and analytical instruments account for 27% and 22% of revenue, respectively. Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Illumina Inc.mehr Analysen

30.07.19 Illumina Hold Canaccord Adams
30.05.19 Illumina Outperform Wolfe Research
09.10.18 Illumina Neutral UBS AG
31.07.18 Illumina Buy Canaccord Adams

Eintrag hinzufügen

Apple Umsatzwarnung sorgt für rote Vorzeichen | BX Swiss TV

Aktien in diesem Artikel

Illumina Inc. 279.37 -5.29% Illumina Inc.
Thermo Fisher Scientific Inc 332.86 6.48% Thermo Fisher Scientific Inc

Finanzen.net News